Indrayani Biotech Ltd
Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
- Market Cap ₹ 66.3 Cr.
- Current Price ₹ 8.49
- High / Low ₹ 18.1 / 6.69
- Stock P/E 75.3
- Book Value ₹ 7.19
- Dividend Yield 0.00 %
- ROCE 6.85 %
- ROE 2.64 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.18 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -5.47% over past five years.
- Promoter holding is low: 33.3%
- Company has a low return on equity of 6.22% over last 3 years.
- Earnings include an other income of Rs.4.32 Cr.
- Company has high debtors of 160 days.
- Promoter holding has decreased over last 3 years: -11.6%
- Working capital days have increased from 127 days to 185 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 49.77 | 20.71 | 57.66 | 74.11 | 61.42 | 37.56 | 27.10 | |
| 0.07 | 0.09 | 0.13 | 0.10 | 0.12 | 0.21 | 47.00 | 25.37 | 51.42 | 65.39 | 55.62 | 32.01 | 24.94 | |
| Operating Profit | -0.07 | -0.09 | -0.13 | -0.10 | -0.12 | -0.21 | 2.77 | -4.66 | 6.24 | 8.72 | 5.80 | 5.55 | 2.16 |
| OPM % | 5.57% | -22.50% | 10.82% | 11.77% | 9.44% | 14.78% | 7.97% | ||||||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.20 | -3.85 | 0.22 | 0.14 | 3.62 | 3.52 | 4.32 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.15 | 1.97 | 1.89 | 2.85 | 4.96 | 7.40 | 3.46 |
| Depreciation | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.40 | 0.34 | 0.93 | 1.45 | 1.02 | 1.92 |
| Profit before tax | -0.07 | -0.10 | -0.13 | -0.10 | -0.12 | -0.05 | 0.81 | -10.88 | 4.23 | 5.08 | 3.01 | 0.65 | 1.10 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.39% | 51.50% | -123.08% | |
| -0.07 | -0.10 | -0.13 | -0.10 | -0.12 | -0.05 | 0.81 | -10.89 | 4.23 | 5.06 | 1.46 | 1.45 | 0.88 | |
| EPS in Rs | -0.11 | -0.16 | -0.21 | -0.16 | -0.19 | -0.08 | 1.31 | -1.86 | 0.72 | 0.86 | 0.19 | 0.19 | 0.12 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | -13% |
| TTM: | -39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 12% |
| 3 Years: | -30% |
| TTM: | 115% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -3% |
| 3 Years: | -51% |
| 1 Year: | -49% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 6% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 34.23 | 34.23 | 34.23 | 45.54 | 45.54 | 45.54 |
| Reserves | -0.29 | -0.39 | -0.52 | -4.12 | -4.25 | -4.30 | 27.19 | -14.28 | -10.05 | 7.67 | 8.98 | 9.80 | 10.59 |
| 0.15 | 0.26 | 0.40 | 0.48 | 0.60 | 0.64 | 13.74 | 15.43 | 16.73 | 51.96 | 63.46 | 61.66 | 66.44 | |
| 0.01 | 0.02 | 0.01 | 0.00 | 0.02 | 0.03 | 6.91 | 4.47 | 8.53 | 6.44 | 8.02 | 13.68 | 6.27 | |
| Total Liabilities | 3.51 | 3.53 | 3.53 | 0.00 | 0.01 | 0.01 | 51.48 | 39.85 | 49.44 | 100.30 | 126.00 | 130.68 | 128.84 |
| 3.51 | 3.50 | 3.50 | 0.00 | 0.00 | 0.00 | 17.36 | 15.11 | 15.33 | 23.81 | 21.66 | 16.66 | 16.28 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.59 | 13.72 | 13.22 | 12.72 | 18.03 | 18.09 | 18.09 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.19 | 0.19 | 7.99 | 9.56 | 9.61 | 9.61 |
| 0.00 | 0.03 | 0.03 | 0.00 | 0.01 | 0.01 | 20.52 | 10.83 | 20.70 | 55.78 | 76.75 | 86.32 | 84.86 | |
| Total Assets | 3.51 | 3.53 | 3.53 | 0.00 | 0.01 | 0.01 | 51.48 | 39.85 | 49.44 | 100.30 | 126.00 | 130.68 | 128.84 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.06 | -0.09 | -0.13 | -0.10 | -0.12 | -0.21 | 5.96 | 0.52 | 3.47 | 8.33 | 26.09 | 17.35 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.67 | -0.56 | 0.59 | -14.09 | -7.26 | -1.34 | |
| 0.02 | 0.12 | 0.14 | 0.08 | 0.13 | 0.20 | -1.28 | -0.73 | -3.23 | 4.93 | -19.19 | -16.22 | |
| Net Cash Flow | -0.04 | 0.02 | 0.01 | -0.03 | 0.01 | 0.00 | 1.01 | -0.78 | 0.82 | -0.83 | -0.36 | -0.20 |
| Free Cash Flow | -0.06 | -0.09 | -0.13 | -0.10 | -0.12 | -0.21 | 2.50 | 0.15 | 3.41 | 6.43 | 19.75 | 16.50 |
| CFO/OP | 86% | 100% | 100% | 100% | 100% | 100% | 215% | -11% | 56% | 96% | 450% | 313% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 51.63 | 84.07 | 81.53 | 79.93 | 104.59 | 159.95 | ||||||
| Inventory Days | 56.98 | 25.01 | 12.59 | 16.36 | 19.94 | 41.74 | ||||||
| Days Payable | 70.35 | 79.21 | 59.29 | 13.72 | 28.24 | 211.39 | ||||||
| Cash Conversion Cycle | 38.26 | 29.87 | 34.84 | 82.57 | 96.28 | -9.70 | ||||||
| Working Capital Days | 30.21 | -58.51 | -12.15 | 77.08 | 117.19 | 185.42 | ||||||
| ROCE % | -1.99% | -2.85% | -3.70% | -5.68% | 8.80% | -12.01% | 16.04% | 12.51% | 7.52% | 6.85% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees employees |
|
|||||||
| Number of Subsidiaries and Step-Down Subsidiaries entities |
||||||||
| Cities Served (A-Diet Express Hospitality) cities |
||||||||
| Farming Land (HSL Agri Solutions) acres |
||||||||
| Meals per Day Capacity (A-Diet Express) meals/day |
||||||||
| Boiler Manufacturing Capacity (Matrix Boilers) TPH |
||||||||
| Milk Procurement per Day (Dindigul Farm Product) liters/day |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliance Certificate Under Reg 74(5) Of SEBI (DP) Reg, 2018.
11h - Compliance Certificate Under Reg 74(5) of SEBI (Depositories and Participants) Regulation, 2018, for the quarter ended on 30th June, 2026.
-
Closure of Trading Window
27 Jun - Trading window closes from July 1, 2026 until 48 hours after Q1 FY2026 results.
-
Outcome Of The Rights Issue Committee Meeting Held On 22Nd June, 2026
22 Jun - Indrayani Biotech postponed its partly paid-up rights issue schedule until further notice.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
3 Jun - Mrs. Ranya Ravi resigned as Company Secretary and Compliance Officer, effective 3 June 2026.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Annual secretarial compliance report for FY2026 cites multiple SEBI LODR delays/fines; partly paid-up rights issue letter of offer circulating.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure